Sekisui Chemical (4204) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
1 Nov, 2025Executive summary
First-half net sales reached a record ¥629.8 billion, but operating profit declined to ¥45.4 billion due to weak market conditions, especially in the auto and EV sectors, and one-off European expenses, missing forecasts.
Ordinary profit increased to ¥49.0 billion, aided by foreign exchange gains, but profit attributable to owners dropped to ¥31.7 billion due to lower gains on investment securities.
Full-year guidance was revised, with net sales forecast at ¥1,323.2 billion and operating profit at ¥110.0 billion, reflecting challenging market conditions.
Annual dividend per share is planned at ¥80, marking the 16th consecutive year of dividend growth, with significant share buybacks and a total return ratio near 100%.
Comprehensive income surged 96% to ¥46.7 billion, driven by improved foreign currency translation and securities valuation.
Financial highlights
1H FY2025 net sales: ¥629.8 billion (+0.1% YoY); operating profit: ¥45.4 billion (-6.7% YoY); ordinary profit: ¥49.0 billion (+1.7% YoY); profit attributable to owners: ¥31.7 billion (-26.1% YoY).
Gross profit margin: 32.2%; operating margin: 7.2%; EPS: ¥76.47.
Interim dividend: ¥40 per share, up ¥3 YoY.
Total assets: ¥1,374.8 billion; net assets: ¥853.9 billion; equity-to-asset ratio: 60.0%.
EBITDA for 1H FY2025 was ¥73.8 billion; ROE: 9.0%.
Outlook and guidance
2H FY2025 net sales forecast at ¥693.4 billion; operating profit expected to rebound to ¥64.6 billion.
Full-year net sales planned at ¥1,323.2 billion (+2.0% YoY); operating profit at ¥110.0 billion (+1.9% YoY); profit attributable to owners at ¥72.0 billion (-12.1% YoY).
Dividend to rise to ¥80 per share for the year, with additional share buybacks totaling 14 million shares.
Growth expected across all segments in 2H, focusing on high-performance products and cost control.
Forecast revision reflects weaker-than-expected market conditions.
Latest events from Sekisui Chemical
- Record sales achieved, but profits fell on impairment and one-time costs.4204
Q3 20263 Feb 2026 - Record Q1 profits and raised first-half outlook driven by strong demand and FX gains.4204
Q1 20252 Feb 2026 - Record-high H1 sales and profit drive upward guidance and continued dividend growth.4204
Q2 202517 Jan 2026 - Record sales and profits achieved, with full-year profit and dividend forecasts raised.4204
Q3 20259 Jan 2026 - Record profits and sales achieved, with further gains and dividend growth targeted for FY 2025.4204
Q4 202524 Dec 2025 - Record sales and operating profit, but net income fell sharply on FX and investment losses.4204
Q1 202616 Nov 2025